The FDA has accepted a new drug application for Kala Pharmaceuticals’ KPI-121 0.25% for the temporary relief of dry eye signs and symptoms, the company announced in a press release.The drug uses Kala’s AMPPLIFY mucus-penetrating particle drug delivery …
Author: Healio ophthalmology
OSN’s top news of the week
Here are some top stories on Healio.com/OSN from the past week: Increase in choroidal thickness seen after CPAP therapyPatients with obstructive sleep apnea syndrome who underwent continuous positive airway pressure therapy experienced an increase in c…
Read OSN’s Dec. 25 publication exclusives online
The cover story in the Dec. 25, 2018, issue of Ocular Surgery News focused on the FDA approval process for ophthalmology in 2018.Here are some of the issue’s publication exclusives: Cover StoryImproved communication evident in FDA approval process for …
2018’s top five retina stories
Retina news in 2018 included study results, an FDA approval and live coverage of the American Society of Retina Specialists and Euretina meetings.Here are the top five most-read retina-related articles on Healio.com/OSN this year:Hundreds of clinics in…
BVI acquires PhysIOL Group
Beaver-Visitec International will acquire the Belgium-based IOL company PhysIOL Group from TA Associates, BVI announced in a press release.Backed by TPG Capital, the deal will close in the first quarter of 2019.PhysIOL CEO Marc Nolet will keep a leader…
Last patient dosed in Aldeyra allergic conjunctivitis treatment trial
The last patient in the ALLEVIATE phase 3 trial of topical ocular reproxalap for allergic conjunctivitis has been dosed, Aldeyra Therapeutics announced.The multicenter, double-masked, parallel-group, vehicle-controlled phase 3 clinical trial enrolled m…
MINIject MIGS device reduces IOP, medication usage in early trial
iSTAR Medical’s MINIject device showed significant reduction in IOP and medication burden in a first-in-human trial, the company announced in a press release.The prospective, open, international, multicenter STARI-I trial included 25 patients with mild…
$name
Full Story →
CyPass recall tops 2018 glaucoma news
Alcon called for a voluntary withdraw of its CyPass micro-stent in August after data found significant endothelial cell loss 5 years after implantation. The news was the most-read glaucoma-related article on Healio.com/OSN in 2018.Here are the top five…
Clearside submits NDA for uveitic macular edema treatment
Clearside Biomedical has submitted a new drug application to the FDA for Xipere, its treatment for macular edema associated with uveitis, according to a press release.Xipere, a proprietary suspension of triamcinolone acetonide, is designed to be admini…
Oculomotor system may adapt to head injuries
Subconcussive head impacts negatively affect near point of convergence; however, over time, the oculomotor system could adapt to subclinical brain injuries, according to a study.The prospective case series study measured near point of convergence (NPC)…
Annexon Biosciences closes $75 million funding round
Annexon Biosciences has closed a $75 million Series C round of financing, which will be used to develop multiple product candidates, including an antigen-binding fragment candidate for use in ophthalmic settings, the company announced in a press releas…
Patients with Raindrop near vision inlay at risk for corneal haze
The FDA released a safety communication regarding the Raindrop near vision inlay after a post-approval study found 75% of patients with the inlay developed haze in any location within the cornea.The FDA recommended that the Raindrop near vision inlay, …
Carl Zeiss completes IanTECH acquisition
IanTECH, the developer of the miLOOP lens fragmentation device, has been fully acquired by Carl Zeiss Meditec, according to corporate communications from Zeiss.In addition to the miLOOP, IanTECH has other technologies for lens removal under development…
First IC-8 IOL implanted in US pivotal study
In a pivotal study, the first U.S. patient has been implanted with the IC-8 small aperture IOL, according to an AcuFocus press release.The clear monofocal lens, which has an embedded mini-ring or pinhole in the center to increase a patient’s natural ra…
Alcon acquires Tear Film Innovations
Tear Film Innovations, the manufacturer of the iLux device, has been acquired by Alcon, according to a press release.The iLux device is used by eye care professionals to treat meibomian gland dysfunction. It uses disposable silicone pads to warm the ey…
Your dry eye columnist: Who am I, what am I doing and why
A funny thing happened to me the other day: I got an email about a column I wrote. In itself, this is not really all that unusual. Heck, my friend Prof. Dave Howard of NYU emails me every month with comments on my drivel. As an aside, Dave, you really …
Woman presents with ocular pain, redness and photophobia
A 40-year-old woman with a medical history of acute myeloid leukemia treated with bone marrow transplant, complicated by ocular graft-versus-host disease and penetrating keratoplasty in the right eye, urgently presented to the New England Eye Center at…
What possible FDA approval in 2019 do you believe will have the most impact on ophthalmology?
Click here to view the Cover Story to this Point/Counter.As we continue to have innovation and new ways of approaching the same problems, whether medical or surgical, having new techniques in the clinic and operating room could be groundbreaking for ey…
The secret to a great capsulorrhexis
When we examine an eye that had previous cataract surgery years ago, we see two things: the incision and the capsulorrhexis. And based on those, we sometimes make a judgment as to the skills of the previous surgeon. We have no idea as to the prior post…